Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Price

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Psychiatric Rehabilitation Journal|February 22, 2023
Evaluating the feasibility and potential impacts of a recovery-oriented psychosocial rehabilitation toolkit in a health care setting in Kenya: A mixed-methods studyRegina Casey, Joshua C Wiener, Terry Krupa, et al.
The Journal of Rheumatology|April 3, 2010
Estimating indirect costs in primary Sjögren's syndromeSimon J Bowman, Yvan St Pierre, Nurhan Sutcliffe, et al.
Rheumatology Advances in Practice|January 15, 2026
Development of a clinical tool to identify patients with early inflammatory arthritis at high risk of employment loss: analysis from the National Early Inflammatory Arthritis AuditEd Alveyn, Katie Bechman, Maryam Adas, et al.
British Journal of Haematology|June 17, 2026
Outcome of treatment with trametinib in adults with histiocytic neoplasms in the United KingdomRodothea Amerikanou, Talha Munir, Kristian Bowles, et al.
Rheumatology (Oxford, England)|November 1, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort studyMark D Russell, Zijing Yang, Niamh Dooley, et al.
The Lancet. Rheumatology|October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort studyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Environment, Development and Sustainability|January 11, 2021
COVID-19: the impact of a global crisis on sustainable development teachingWalter Leal Filho, Elizabeth Price, Tony Wall, et al.
Blood Cells, Molecules & Diseases|July 29, 2014
A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mLElizabeth Price, Andrew S Artz, Huiman Barnhart, et al.
Rheumatology (Oxford, England)|December 17, 2020
The management of Sjögren's syndrome: British Society for Rheumatology guideline scopeElizabeth Price, Alexander Allen, Saaeha Rauz, et al.
Rheumatology (Oxford, England)|June 5, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort studyMaryam A Adas, Katie Bechman, Mark D Russell, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Psychiatric Rehabilitation Journal|February 22, 2023
Evaluating the feasibility and potential impacts of a recovery-oriented psychosocial rehabilitation toolkit in a health care setting in Kenya: A mixed-methods studyRegina Casey, Joshua C Wiener, Terry Krupa, et al.
The Journal of Rheumatology|April 3, 2010
Estimating indirect costs in primary Sjögren's syndromeSimon J Bowman, Yvan St Pierre, Nurhan Sutcliffe, et al.
Rheumatology Advances in Practice|January 15, 2026
Development of a clinical tool to identify patients with early inflammatory arthritis at high risk of employment loss: analysis from the National Early Inflammatory Arthritis AuditEd Alveyn, Katie Bechman, Maryam Adas, et al.
British Journal of Haematology|June 17, 2026
Outcome of treatment with trametinib in adults with histiocytic neoplasms in the United KingdomRodothea Amerikanou, Talha Munir, Kristian Bowles, et al.
Rheumatology (Oxford, England)|November 1, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort studyMark D Russell, Zijing Yang, Niamh Dooley, et al.
The Lancet. Rheumatology|October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort studyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Environment, Development and Sustainability|January 11, 2021
COVID-19: the impact of a global crisis on sustainable development teachingWalter Leal Filho, Elizabeth Price, Tony Wall, et al.
Blood Cells, Molecules & Diseases|July 29, 2014
A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mLElizabeth Price, Andrew S Artz, Huiman Barnhart, et al.
Rheumatology (Oxford, England)|December 17, 2020
The management of Sjögren's syndrome: British Society for Rheumatology guideline scopeElizabeth Price, Alexander Allen, Saaeha Rauz, et al.
Rheumatology (Oxford, England)|June 5, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort studyMaryam A Adas, Katie Bechman, Mark D Russell, et al.
Pageof 8